SPIRIT 2: Efficacy and Safety Study of Relugolix in Women With Endometriosis-Associated Pain
Clinical trial NCT03204331 · COMPLETED
Trial details
- NCT number
- NCT03204331
- Sponsor
- Myovant Sciences GmbH
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-01
- Primary completion
- 2020-04-01
- Enrollment
- 623
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.